retatrutide type 2 diabetes phase 2 trial hba1c is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 ๐ A triple-action once-weekly injection
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 29 - Nov 3


























